Animal models and analytical approaches for understanding the relationships between wine and cancer

Drugs under Experimental and Clinical Research

Volumn 31, Issue 1, 2005, Pages 19-27

  Ebeler, S E ^a   Dingley, K H ^b   Ubick, E ^b   Abel, S ^a   Mitchell, A E ^a   Burns, S A ^a   Steinberg, F M ^a   Clifford, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ALCOHOL; CARCINOGEN; ISOTHIOCYANIC ACID DERIVATIVE; PHENYLETHYL ISOTHIOCYANATE; POLYPHENOL; QUERCETIN; SULFORAPHANE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DNA ADDUCT; FEMALE; FOOD COMPOSITION; MALE; MASS SPECTROMETRY; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; RED WINE; SOLID; TRANSGENIC MOUSE; WINE;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CATECHIN; DISEASE MODELS, ANIMAL; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMIDAZOLES; LIVER FUNCTION TESTS; MALE; MICE; MICE, TRANSGENIC; NEUROFIBROMATOSES; QUERCETIN; RATS; RATS, INBRED F344; VITIS; WINE;

EID: 16244420704     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Grønbaek M., Becker U., Johansen D., et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann. Intern. Med., 133, 411, 2000.
2. Grønbaek M., Deis A., Słrensen T.I.A., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ, 310, 1169, 1995.
3. Nerenberg M., Hinrichs S.H., Reynolds R.K., Khoury G., Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science, 237, 1324, 1987.
4. Ebeler S.E., Brenneman C.A., Kim G.-S., et al. Dietary catechin delays tumor onset in a transgenic mouse model. Am. J. Clin. Nutr., 76, 865, 2002.
5. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98, 503, 1975.
6. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137, 266, 1984.
7. Clifford A.J., Ebeler S.E., Ebeler J.D., et al. Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids. Am. J. Clin. Nutr., 64, 748, 1996.
8. Ebeler S.E., Clifford A.J., Ebeler J.D., Bills N.D., Hinrichs S.H. An in vivo experimental protocol for identifying and evaluating dietary factors that delay tumor onset. In: Watkins T1R. (Ed.). "Wine: Nutritional and Therapeutic Benefits." American Chemical Society, Washington, D.C., 1997, pp. 215-229
9. Zoecklein B.S., Fugelsang K.C., Gump B.H., Nury F.S. "Wine Analysis and Production." Chapman and Hall, New York, 1995, p. 621.
10. Khanduja K.L., Gandhi R.K., Pathania V., Syal N. Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem. Toxicol, 37, 313, 1999.
11. Ghazali R.A., Waring R.H. The effects of flavonoids on human phenolsulphotransferases: Potential in drug metabolism and chemoprevention. Life Sci., 65, 1625, 1999,
12. Chou H.C., Lang N.P., Kadlubar F.F. Metabolic-activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferease(s). Cancer Res., 55, 525, 1995.
13. Talalay P., Zhang Y. Chemoprotection against cancer by isothiocyanates and glucosinolates. Biochem. Soc. Trans., 24, 806, 1996.
14. Dingley K.H., Ubick E.A., Chiarappa-Zucca M.L., et al. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhlP and IQ and phase II hepatic enzymes. Nutr. Cancer, 46(2), 212, 2003.
15. Mauthe R.J., Dingley K.H., Leveson S.H., et al. Comparison of DNA-adduct and tissue-available dose levels of MelQx in human and rodent colon following administration of a very low dose. Int. J Cancer, 80, 539, 1999,
16. Vogel J.S., Turteltaub K.W., Finkel R., Nelson D.E. Accelerator mass spectrometry. Isotope quantification at attomole sensitivity. Anal. Chem., 67, 353A, 1995.
17. Hinrichs S.H., Nerenberg M., Reynolds R.K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science, 237, 1340, 1987.
18. Baird A.M., Green J.E., Hinrichs S.H. Animal models of human disease. Comp. Path. Bull., 24, 3, 1992.
19. Turteltaub K.W., Dingley K.H. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification. Toxicol. Lett., 102, 435, 1998.
20. Shields P.G., Harris C.C. Molecular epidemiology and the genetics of environmental cancer. JAMA, 266, 681, 1991.
21. Hammons G.J., Fletcher J.V., Stepps K.R., et al. Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhlP and 4-aminobiphenyl in human and rat liver microsomes. Nutr. Cancer, 33, 46, 1999.
22. De Long M.J., Prochaska H.J., Talalay P. Induction of NAD(P)H, quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: A model system for the study of anticarcinogens. PNAS, 83, 787, 1986.
23. Kurata M., Suzuki M., Takeda K. Effects of phenol compounds, glutathione analogues and a diuretic drug on glutathione S-transferase, glutathione reductase and glutathione peroxidase from canine erythrocytes. Comp. Biochem Physiol., 103B, 863, 1991.
24. Williamson G., Plumb G.W., Uda Y., Price K.R., Rhodes M.J.C. Dietary quercetin glycosides: Antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinone reductase in Hepa1c1c7 cells. Carcinogenesis, 17, 2385, 1996,
25. Ritchey J.G., Waterhouse A.L. A standard red wine: Monomeric phenolic analysis of commercial Cabernet Sauvignon wines. Am. J. Enol. Vitic., 50, 91, 1999.
26. Singleton V.L., Noble A.C. Wine flavor and phenolic substances. In: Charalambous G., Katz I. (Eds.), "Phenolic, Sulfur, and Nitrogen Compounds in Food Flavors." American Chemical Society, Washington, D.C., 1976. pp. 47-70.
27. Hertog M.G.L., Hollman P.C.H. Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr., 50, 63, 1996.